News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Naveen Pemmaraju: SMAC Mimetics as Potential Cancer Therapeutics in Myeloid Malignancies
Naveen Pemmaraju/mdanderson.org
May 23, 2025, 06:34

Naveen Pemmaraju: SMAC Mimetics as Potential Cancer Therapeutics in Myeloid Malignancies

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, posted on X:

“SMAC Mimetics/IAP antagonist in myeloid malignancies. British Journal of Haematology.”

Title: SMAC Mimetics as Potential Cancer Therapeutics in Myeloid Malignancies

Authors: Prajwal Boddu, Bing Z. Carter, Srdan Verstovsek, Naveen Pemmaraj

Read The Full Article at British Journal of Haematology.

Naveen Pemmaraju: SMAC Mimetics as Potential Cancer Therapeutics in Myeloid Malignancies

More posts featuring Naveen Pemmaraju.

Bing Z. Carter British Journal of Haematology cancer myeloid malignancies Naveen Pemmaraj Naveen Pemmaraju OncoDaily Oncology Potential Cancer Therapeutics Prajwal Boddu Srdan Verstovsek
Special Coverage
Insight
Aug 16, 2025, 22:13
John Oluwafemi Teibo: New Insights into CAR-T Molecular Effectors and Signaling Pathways
Voices
Aug 16, 2025, 21:51
Paolo Bossi: How to Intercept Malignant Transformation
Positive
Aug 16, 2025, 21:38
IASLC Congratulates Chelisa Cardinez on 2025 Early Career Grant Award
Voices
Aug 16, 2025, 21:17
Abdu Adem Yesufe: Radiotherapy Training in Dubai with Varian Oncology Systems and ELMED Medical Systems
Voices
Aug 16, 2025, 21:07
George Weiner: Press Forward - Advice to Early Career Researchers in Times of Uncertainty
Positive
Aug 16, 2025, 21:05
32 Million Cancer Survivors and Counting - UICC
Voices
Aug 16, 2025, 20:49
Register by August 18: AACR Special Conference on Cancer Immunity and Cancer-Related Autoimmunity
Insight
Aug 16, 2025, 20:40
Liang Cheng: Redefining Bladder Cancer Care with Urinary DNA Insights
Insight
Aug 16, 2025, 20:38
Eduardo Bruera: Why Do Argentinian Oncologists Refer Patients Late for Palliative Care?
Voices
Aug 16, 2025, 20:29
Rob Winn: From Leukemia Diagnosis to Remission and Advocacy
Societies
Aug 16, 2025, 20:27
The Faces of Discovery - Peter MacCallum Cancer Centre
Voices
Aug 16, 2025, 20:22
Gregg Margolis: Three Must-Read Health Policy Stories This Week